Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arbutus Biopharma Corp
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arbutus Biopharma Corp since year 2005.
Table 2 shows the detailed insider transactions of Arbutus Biopharma Corp since 2005.
The reporting company's ticker symbol is ABUS. The reporting company's CIK number is 1447028.
The total value of stock buying since 2005 is $6,950.
The total value of stock sales since 2005 is $191,390.
The total value of stock option exercises since 2005 is $119,458.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-04-17||Murray Mark J. (President & CEO)||Option Ex||27,007||.35||9,560|
|2017-10-03||Sofia Michael J. (Chief Scientific Officer)||Sale||10,000||8.00||80,000|
|2017-08-15||Sofia Michael J. (Chief Scientific Officer)||Sale||30,000||3.71||111,390|
|2016-08-16||Abrams Michael J. (Managing Director)||Option Ex||14,178||.35||4,905|
|2015-09-11||Murray Mark J. (President & CEO)||Option Ex||219,428||.44||97,426|
|2015-09-11||Abrams Michael J. (Managing Director)||Option Ex||17,044||.44||7,567|
|2015-08-24||Henriques Richard C Jr||Buy||1,000||6.95||6,950|
Insider trading activities including stock purchases, stock sales, and option exercises of ABUS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arbutus Biopharma Corp (symbol ABUS, CIK number 1447028) see the Securities and Exchange Commission (SEC) website.